Column Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-324
Closed -$65.5K 862
2022
Q4
$65.5K Hold
324
0.01% 264
2022
Q3
$57K Sell
324
-330
-50% -$67.6K 0.01% 256
2022
Q2
$132K Hold
654
0.03% 155
2022
Q1
$148K Hold
654
0.03% 154
2021
Q4
$177K Hold
654
0.03% 139
2021
Q3
$158K Hold
654
0.03% 145
2021
Q2
$155K Sell
654
-452
-41% -$103K 0.03% 142
2021
Q1
$242K Hold
1,106
0.05% 102
2020
Q4
$193K Hold
1,106
0.05% 110
2020
Q3
$179K Sell
1,106
-312
-22% -$49.4K 0.05% 101
2020
Q2
$202K Hold
1,418
0.07% 86
2020
Q1
$154K Hold
1,418
0.06% 85
2019
Q4
$206K Buy
+1,418
New +$205K 0.1% 84

Other funds holding LH

Column Capital Advisors's LH Position: Q1 2023 in Review

Column Capital Advisors sold out of Labcorp (LH) in Q1 2023, closing a stake of 324 shares — an estimated $65.5K sold.

Column Capital Advisors first reported a position in LH in Q4 2019 and held it in 13 quarters. The position peaked at $242K in Q1 2021. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • Column Capital Advisors reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • Column Capital Advisors sold 324 Labcorp shares in Q1 2023, an estimated $65.5K.
  • Column Capital Advisors first reported a position in Labcorp in Q4 2019 and held it in 13 quarters.
  • Column Capital Advisors's Labcorp position peaked at $242K in Q1 2021.
  • 940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Column Capital Advisors's 13F filing for Q1 2023, filed 9 May 2023.